发明名称 1-phenyl-4-(1-(2-aryl)cyclopropyl) methylpiperazines: dopamine receptor ligands
摘要 Disclosed are compounds of formula (I) or pharmaceutically acceptable addition salts thereof wherein: R1, R2, R3, R4 and R5, R6, R7 and R8 represent organic and/or inorganic substituents as defined herein, which compounds are useful for the treatment and/or prevention of neuropsychological disorders including, but not limited to, schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, Parkinson-like motor disorders and motion disorders related to the use of neuroleptic agents.
申请公布号 AU2720300(A) 申请公布日期 2000.07.24
申请号 AU20000027203 申请日期 2000.01.06
申请人 NEUROGEN CORPORATION 发明人 XIAOYAN ZHANG;JENNIFER TRAN;HE ZHAO;ANDREW THURKAUF
分类号 C07D295/02;A61K31/495;A61P25/00;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/30;C07D295/03;C07D295/04;C07D295/06;C07D295/073;C07D295/135 主分类号 C07D295/02
代理机构 代理人
主权项
地址